Loading…

Accuracy of the New ICD-9-CM Code for “Drip-and-Ship” Thrombolytic Treatment in Patients With Ischemic Stroke

A new International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis code, V45.88, was approved by the Centers for Medicare and Medicaid Services (CMS) on October 1, 2008. This code identifies patients in whom intravenous (IV) recombinant tissue plasminogen acti...

Full description

Saved in:
Bibliographic Details
Published in:Journal of stroke and cerebrovascular diseases 2012-02, Vol.21 (2), p.121-123
Main Authors: Tonarelli, Silvina B., MD, Tibbs, Michael, PhD, Vazquez, Gabriela, PhD, Lakshminarayan, Kamakshi, PhD, MD, Rodriguez, Gustavo J., MD, Qureshi, Adnan I., MD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c458t-8cb7b51471b71c1b75572ce087ea69d49df53bcfc9ef17b4e9c8b8fede95b2b3
cites cdi_FETCH-LOGICAL-c458t-8cb7b51471b71c1b75572ce087ea69d49df53bcfc9ef17b4e9c8b8fede95b2b3
container_end_page 123
container_issue 2
container_start_page 121
container_title Journal of stroke and cerebrovascular diseases
container_volume 21
creator Tonarelli, Silvina B., MD
Tibbs, Michael, PhD
Vazquez, Gabriela, PhD
Lakshminarayan, Kamakshi, PhD, MD
Rodriguez, Gustavo J., MD
Qureshi, Adnan I., MD
description A new International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis code, V45.88, was approved by the Centers for Medicare and Medicaid Services (CMS) on October 1, 2008. This code identifies patients in whom intravenous (IV) recombinant tissue plasminogen activator (rt-PA) is initiated in one hospital's emergency department, followed by transfer within 24 hours to a comprehensive stroke center, a paradigm commonly referred to as “drip-and-ship.” This study assessed the use and accuracy of the new V45.88 code for identifying ischemic stroke patients who meet the criteria for drip-and-ship at 2 advanced certified primary stroke centers. Consecutive patients over a 12-month period were identified by primary ICD-9-CM diagnosis codes related to ischemic stroke. The accuracy of V45.88 code utilization using administrative data provided by Health Information Management Services was assessed through a comparison with data collected in prospective stroke registries maintained at each hospital by a trained abstractor. Out of a total of 428 patients discharged from both hospitals with a diagnosis of ischemic stroke, 37 patients were given ICD-9-CM code V45.88. The internally validated data from the prospective stroke database demonstrated that a total of 40 patients met the criteria for drip-and-ship. A concurrent comparison found that 92% (sensitivity) of the patients treated with drip-and-ship were coded with V45.88. None of the non-drip-and-ship stroke cases received the V45.88 code (100% specificity). The new ICD-9-CM code for drip-and-ship appears to have high specificity and sensitivity, allowing effective data collection by the CMS.
doi_str_mv 10.1016/j.jstrokecerebrovasdis.2010.05.011
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_918934792</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S105230571000131X</els_id><sourcerecordid>918934792</sourcerecordid><originalsourceid>FETCH-LOGICAL-c458t-8cb7b51471b71c1b75572ce087ea69d49df53bcfc9ef17b4e9c8b8fede95b2b3</originalsourceid><addsrcrecordid>eNqVks1u1DAURiMEoqXwCsg7JKQMthNPkg1SSQuMNPxIMxLsLPvmRnGaxFPbKZpdHwRerk-ChyksEBs29l0cfdc--pLkJaMLRtnyVb_ofXD2CgEdamdvlG-MX3AaASoWlLEHySkTGU9LwdjDOFPB04yK4iR54n1PIyFK8Tg54TQSS85Pk-tzgNkp2BPbktAh-YjfyKq-SKu0_kBq2yBprSN3t98vnNmlamrSTWd2d7c_yLZzdtR22AcDZOtQhRGnQMxEPqtg4ujJFxM6svLQ4RiZza_HP00etWrw-Oz-Pku2by-39ft0_endqj5fp5CLMqQl6EILlhdMFwziIUTBAWlZoFpWTV41rcg0tFBhywqdYwWlLltssBKa6-wseXGM3Tl7PaMPcjQecBjUhHb2smJlleVFxSP55kiCs947bOXOmVG5vWRUHsTLXv5LvDyIl1TIqDWGPL9fN-sRmz8Rv01HYH0EMP75xqCTHqIkwMY4hCAba_5v3-u_4mAwkwE1XOEefW9nN0W7kknPJZWbQxUOTWA0tiBjX7OfwxG6HQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>918934792</pqid></control><display><type>article</type><title>Accuracy of the New ICD-9-CM Code for “Drip-and-Ship” Thrombolytic Treatment in Patients With Ischemic Stroke</title><source>Elsevier</source><creator>Tonarelli, Silvina B., MD ; Tibbs, Michael, PhD ; Vazquez, Gabriela, PhD ; Lakshminarayan, Kamakshi, PhD, MD ; Rodriguez, Gustavo J., MD ; Qureshi, Adnan I., MD</creator><creatorcontrib>Tonarelli, Silvina B., MD ; Tibbs, Michael, PhD ; Vazquez, Gabriela, PhD ; Lakshminarayan, Kamakshi, PhD, MD ; Rodriguez, Gustavo J., MD ; Qureshi, Adnan I., MD</creatorcontrib><description>A new International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis code, V45.88, was approved by the Centers for Medicare and Medicaid Services (CMS) on October 1, 2008. This code identifies patients in whom intravenous (IV) recombinant tissue plasminogen activator (rt-PA) is initiated in one hospital's emergency department, followed by transfer within 24 hours to a comprehensive stroke center, a paradigm commonly referred to as “drip-and-ship.” This study assessed the use and accuracy of the new V45.88 code for identifying ischemic stroke patients who meet the criteria for drip-and-ship at 2 advanced certified primary stroke centers. Consecutive patients over a 12-month period were identified by primary ICD-9-CM diagnosis codes related to ischemic stroke. The accuracy of V45.88 code utilization using administrative data provided by Health Information Management Services was assessed through a comparison with data collected in prospective stroke registries maintained at each hospital by a trained abstractor. Out of a total of 428 patients discharged from both hospitals with a diagnosis of ischemic stroke, 37 patients were given ICD-9-CM code V45.88. The internally validated data from the prospective stroke database demonstrated that a total of 40 patients met the criteria for drip-and-ship. A concurrent comparison found that 92% (sensitivity) of the patients treated with drip-and-ship were coded with V45.88. None of the non-drip-and-ship stroke cases received the V45.88 code (100% specificity). The new ICD-9-CM code for drip-and-ship appears to have high specificity and sensitivity, allowing effective data collection by the CMS.</description><identifier>ISSN: 1052-3057</identifier><identifier>EISSN: 1532-8511</identifier><identifier>DOI: 10.1016/j.jstrokecerebrovasdis.2010.05.011</identifier><identifier>PMID: 20851622</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Academic Medical Centers ; Brain Ischemia - classification ; Brain Ischemia - diagnosis ; Brain Ischemia - drug therapy ; Cardiovascular ; Centers for Medicare and Medicaid Services (U.S.) ; Data Collection ; drip and ship ; Emergency Service, Hospital - classification ; Fibrinolytic Agents - administration &amp; dosage ; Hospitals, Community ; Hospitals, Rural ; Humans ; ICD-9 code ; International Classification of Diseases ; ischemic stroke ; Neurology ; Patient Transfer - classification ; Recombinant Proteins - administration &amp; dosage ; Registries ; rt-PA ; stroke ; Stroke - classification ; Stroke - diagnosis ; Stroke - drug therapy ; Terminology as Topic ; Thrombolytic Therapy - classification ; thrombolytics ; Time Factors ; Tissue Plasminogen Activator - administration &amp; dosage ; United States ; V 45.88</subject><ispartof>Journal of stroke and cerebrovascular diseases, 2012-02, Vol.21 (2), p.121-123</ispartof><rights>National Stroke Association</rights><rights>2012 National Stroke Association</rights><rights>Copyright © 2012 National Stroke Association. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c458t-8cb7b51471b71c1b75572ce087ea69d49df53bcfc9ef17b4e9c8b8fede95b2b3</citedby><cites>FETCH-LOGICAL-c458t-8cb7b51471b71c1b75572ce087ea69d49df53bcfc9ef17b4e9c8b8fede95b2b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20851622$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tonarelli, Silvina B., MD</creatorcontrib><creatorcontrib>Tibbs, Michael, PhD</creatorcontrib><creatorcontrib>Vazquez, Gabriela, PhD</creatorcontrib><creatorcontrib>Lakshminarayan, Kamakshi, PhD, MD</creatorcontrib><creatorcontrib>Rodriguez, Gustavo J., MD</creatorcontrib><creatorcontrib>Qureshi, Adnan I., MD</creatorcontrib><title>Accuracy of the New ICD-9-CM Code for “Drip-and-Ship” Thrombolytic Treatment in Patients With Ischemic Stroke</title><title>Journal of stroke and cerebrovascular diseases</title><addtitle>J Stroke Cerebrovasc Dis</addtitle><description>A new International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis code, V45.88, was approved by the Centers for Medicare and Medicaid Services (CMS) on October 1, 2008. This code identifies patients in whom intravenous (IV) recombinant tissue plasminogen activator (rt-PA) is initiated in one hospital's emergency department, followed by transfer within 24 hours to a comprehensive stroke center, a paradigm commonly referred to as “drip-and-ship.” This study assessed the use and accuracy of the new V45.88 code for identifying ischemic stroke patients who meet the criteria for drip-and-ship at 2 advanced certified primary stroke centers. Consecutive patients over a 12-month period were identified by primary ICD-9-CM diagnosis codes related to ischemic stroke. The accuracy of V45.88 code utilization using administrative data provided by Health Information Management Services was assessed through a comparison with data collected in prospective stroke registries maintained at each hospital by a trained abstractor. Out of a total of 428 patients discharged from both hospitals with a diagnosis of ischemic stroke, 37 patients were given ICD-9-CM code V45.88. The internally validated data from the prospective stroke database demonstrated that a total of 40 patients met the criteria for drip-and-ship. A concurrent comparison found that 92% (sensitivity) of the patients treated with drip-and-ship were coded with V45.88. None of the non-drip-and-ship stroke cases received the V45.88 code (100% specificity). The new ICD-9-CM code for drip-and-ship appears to have high specificity and sensitivity, allowing effective data collection by the CMS.</description><subject>Academic Medical Centers</subject><subject>Brain Ischemia - classification</subject><subject>Brain Ischemia - diagnosis</subject><subject>Brain Ischemia - drug therapy</subject><subject>Cardiovascular</subject><subject>Centers for Medicare and Medicaid Services (U.S.)</subject><subject>Data Collection</subject><subject>drip and ship</subject><subject>Emergency Service, Hospital - classification</subject><subject>Fibrinolytic Agents - administration &amp; dosage</subject><subject>Hospitals, Community</subject><subject>Hospitals, Rural</subject><subject>Humans</subject><subject>ICD-9 code</subject><subject>International Classification of Diseases</subject><subject>ischemic stroke</subject><subject>Neurology</subject><subject>Patient Transfer - classification</subject><subject>Recombinant Proteins - administration &amp; dosage</subject><subject>Registries</subject><subject>rt-PA</subject><subject>stroke</subject><subject>Stroke - classification</subject><subject>Stroke - diagnosis</subject><subject>Stroke - drug therapy</subject><subject>Terminology as Topic</subject><subject>Thrombolytic Therapy - classification</subject><subject>thrombolytics</subject><subject>Time Factors</subject><subject>Tissue Plasminogen Activator - administration &amp; dosage</subject><subject>United States</subject><subject>V 45.88</subject><issn>1052-3057</issn><issn>1532-8511</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqVks1u1DAURiMEoqXwCsg7JKQMthNPkg1SSQuMNPxIMxLsLPvmRnGaxFPbKZpdHwRerk-ChyksEBs29l0cfdc--pLkJaMLRtnyVb_ofXD2CgEdamdvlG-MX3AaASoWlLEHySkTGU9LwdjDOFPB04yK4iR54n1PIyFK8Tg54TQSS85Pk-tzgNkp2BPbktAh-YjfyKq-SKu0_kBq2yBprSN3t98vnNmlamrSTWd2d7c_yLZzdtR22AcDZOtQhRGnQMxEPqtg4ujJFxM6svLQ4RiZza_HP00etWrw-Oz-Pku2by-39ft0_endqj5fp5CLMqQl6EILlhdMFwziIUTBAWlZoFpWTV41rcg0tFBhywqdYwWlLltssBKa6-wseXGM3Tl7PaMPcjQecBjUhHb2smJlleVFxSP55kiCs947bOXOmVG5vWRUHsTLXv5LvDyIl1TIqDWGPL9fN-sRmz8Rv01HYH0EMP75xqCTHqIkwMY4hCAba_5v3-u_4mAwkwE1XOEefW9nN0W7kknPJZWbQxUOTWA0tiBjX7OfwxG6HQ</recordid><startdate>20120201</startdate><enddate>20120201</enddate><creator>Tonarelli, Silvina B., MD</creator><creator>Tibbs, Michael, PhD</creator><creator>Vazquez, Gabriela, PhD</creator><creator>Lakshminarayan, Kamakshi, PhD, MD</creator><creator>Rodriguez, Gustavo J., MD</creator><creator>Qureshi, Adnan I., MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120201</creationdate><title>Accuracy of the New ICD-9-CM Code for “Drip-and-Ship” Thrombolytic Treatment in Patients With Ischemic Stroke</title><author>Tonarelli, Silvina B., MD ; Tibbs, Michael, PhD ; Vazquez, Gabriela, PhD ; Lakshminarayan, Kamakshi, PhD, MD ; Rodriguez, Gustavo J., MD ; Qureshi, Adnan I., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c458t-8cb7b51471b71c1b75572ce087ea69d49df53bcfc9ef17b4e9c8b8fede95b2b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Academic Medical Centers</topic><topic>Brain Ischemia - classification</topic><topic>Brain Ischemia - diagnosis</topic><topic>Brain Ischemia - drug therapy</topic><topic>Cardiovascular</topic><topic>Centers for Medicare and Medicaid Services (U.S.)</topic><topic>Data Collection</topic><topic>drip and ship</topic><topic>Emergency Service, Hospital - classification</topic><topic>Fibrinolytic Agents - administration &amp; dosage</topic><topic>Hospitals, Community</topic><topic>Hospitals, Rural</topic><topic>Humans</topic><topic>ICD-9 code</topic><topic>International Classification of Diseases</topic><topic>ischemic stroke</topic><topic>Neurology</topic><topic>Patient Transfer - classification</topic><topic>Recombinant Proteins - administration &amp; dosage</topic><topic>Registries</topic><topic>rt-PA</topic><topic>stroke</topic><topic>Stroke - classification</topic><topic>Stroke - diagnosis</topic><topic>Stroke - drug therapy</topic><topic>Terminology as Topic</topic><topic>Thrombolytic Therapy - classification</topic><topic>thrombolytics</topic><topic>Time Factors</topic><topic>Tissue Plasminogen Activator - administration &amp; dosage</topic><topic>United States</topic><topic>V 45.88</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tonarelli, Silvina B., MD</creatorcontrib><creatorcontrib>Tibbs, Michael, PhD</creatorcontrib><creatorcontrib>Vazquez, Gabriela, PhD</creatorcontrib><creatorcontrib>Lakshminarayan, Kamakshi, PhD, MD</creatorcontrib><creatorcontrib>Rodriguez, Gustavo J., MD</creatorcontrib><creatorcontrib>Qureshi, Adnan I., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of stroke and cerebrovascular diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tonarelli, Silvina B., MD</au><au>Tibbs, Michael, PhD</au><au>Vazquez, Gabriela, PhD</au><au>Lakshminarayan, Kamakshi, PhD, MD</au><au>Rodriguez, Gustavo J., MD</au><au>Qureshi, Adnan I., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Accuracy of the New ICD-9-CM Code for “Drip-and-Ship” Thrombolytic Treatment in Patients With Ischemic Stroke</atitle><jtitle>Journal of stroke and cerebrovascular diseases</jtitle><addtitle>J Stroke Cerebrovasc Dis</addtitle><date>2012-02-01</date><risdate>2012</risdate><volume>21</volume><issue>2</issue><spage>121</spage><epage>123</epage><pages>121-123</pages><issn>1052-3057</issn><eissn>1532-8511</eissn><abstract>A new International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis code, V45.88, was approved by the Centers for Medicare and Medicaid Services (CMS) on October 1, 2008. This code identifies patients in whom intravenous (IV) recombinant tissue plasminogen activator (rt-PA) is initiated in one hospital's emergency department, followed by transfer within 24 hours to a comprehensive stroke center, a paradigm commonly referred to as “drip-and-ship.” This study assessed the use and accuracy of the new V45.88 code for identifying ischemic stroke patients who meet the criteria for drip-and-ship at 2 advanced certified primary stroke centers. Consecutive patients over a 12-month period were identified by primary ICD-9-CM diagnosis codes related to ischemic stroke. The accuracy of V45.88 code utilization using administrative data provided by Health Information Management Services was assessed through a comparison with data collected in prospective stroke registries maintained at each hospital by a trained abstractor. Out of a total of 428 patients discharged from both hospitals with a diagnosis of ischemic stroke, 37 patients were given ICD-9-CM code V45.88. The internally validated data from the prospective stroke database demonstrated that a total of 40 patients met the criteria for drip-and-ship. A concurrent comparison found that 92% (sensitivity) of the patients treated with drip-and-ship were coded with V45.88. None of the non-drip-and-ship stroke cases received the V45.88 code (100% specificity). The new ICD-9-CM code for drip-and-ship appears to have high specificity and sensitivity, allowing effective data collection by the CMS.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>20851622</pmid><doi>10.1016/j.jstrokecerebrovasdis.2010.05.011</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1052-3057
ispartof Journal of stroke and cerebrovascular diseases, 2012-02, Vol.21 (2), p.121-123
issn 1052-3057
1532-8511
language eng
recordid cdi_proquest_miscellaneous_918934792
source Elsevier
subjects Academic Medical Centers
Brain Ischemia - classification
Brain Ischemia - diagnosis
Brain Ischemia - drug therapy
Cardiovascular
Centers for Medicare and Medicaid Services (U.S.)
Data Collection
drip and ship
Emergency Service, Hospital - classification
Fibrinolytic Agents - administration & dosage
Hospitals, Community
Hospitals, Rural
Humans
ICD-9 code
International Classification of Diseases
ischemic stroke
Neurology
Patient Transfer - classification
Recombinant Proteins - administration & dosage
Registries
rt-PA
stroke
Stroke - classification
Stroke - diagnosis
Stroke - drug therapy
Terminology as Topic
Thrombolytic Therapy - classification
thrombolytics
Time Factors
Tissue Plasminogen Activator - administration & dosage
United States
V 45.88
title Accuracy of the New ICD-9-CM Code for “Drip-and-Ship” Thrombolytic Treatment in Patients With Ischemic Stroke
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T10%3A45%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Accuracy%20of%20the%20New%20ICD-9-CM%20Code%20for%20%E2%80%9CDrip-and-Ship%E2%80%9D%20Thrombolytic%20Treatment%20in%20Patients%20With%20Ischemic%20Stroke&rft.jtitle=Journal%20of%20stroke%20and%20cerebrovascular%20diseases&rft.au=Tonarelli,%20Silvina%20B.,%20MD&rft.date=2012-02-01&rft.volume=21&rft.issue=2&rft.spage=121&rft.epage=123&rft.pages=121-123&rft.issn=1052-3057&rft.eissn=1532-8511&rft_id=info:doi/10.1016/j.jstrokecerebrovasdis.2010.05.011&rft_dat=%3Cproquest_cross%3E918934792%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c458t-8cb7b51471b71c1b75572ce087ea69d49df53bcfc9ef17b4e9c8b8fede95b2b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=918934792&rft_id=info:pmid/20851622&rfr_iscdi=true